Mal Val Ala PAB-N (SO2Me) - Exatecan (Compound LE14) is a conjugate of ADC toxin Exatecan and linker Mal Val Ala PAB-N (SO2Me). Mal Val-Ala-PAB-N (SO2Me) - Hexatecan can be used to synthesize ADC FZ-AD005. FZ-AD005 is an ADC targeting delta like ligand 3 (DLL3, KD=58.3 pM) with anti-tumor activity against SCLC cancer.
In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
In vitro studies: ADC is composed of an antibody, and ADC cytotoxin is connected to the antibody through an ADC adapter.
规格
规格或纯度
≥96%
英文名称
Mal-Val-Ala-PAB-N(SO2Me)-Exatecan
生化机理
Mal-Val-Ala-PAB-N(SO2Me)-Exatecan (Compound LE14) is a conjugate of an ADC toxin Exatecan and a linker Mal-Val-Ala-PAB-N(SO2Me). Mal-Val-Ala-PAB-N(SO2Me)-Exatecan can be used for synthesis of ADC FZ-AD005. FZ-AD005 is a delta-like ligand 3 (DLL3, KD=58.3 pM) targeting ADC, that exhibits antitumor efficacy against SCLC cancer.